NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $565 | +580.7% | 35 | +1650.0% | 0.00% | – |
Q2 2023 | $83 | -77.0% | 2 | -66.7% | 0.00% | – |
Q1 2023 | $361 | -18.0% | 6 | 0.0% | 0.00% | – |
Q4 2022 | $440 | – | 6 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 6 | -25.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 8 | +33.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 6 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |